Given the centrality of these processes in SLE pathogenesis, the enhanced ETS2 expression associated with rs2836882 may contribute to the immune imbalance and tissue damage observed in SLE, particularly in monocyte/macrophage subsets. This evidence concerns the gene ETS2 and systemic lupus erythematosus.